cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-expressing macrophages drive age-related decline Inhibition of CD38 enzymatic activity
Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect The CD38 glycohydrolase and the NAD sink: implications for pathological conditions American Journal of Physiology Cell Physiology American Physiological Society CD38 connects the heart and brain Translational Psychiatry CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect CD38 is a key mediator of NAD+ depletion in the brain of ZIKV infected mice: iScience
Pay in 4 interest-free payments of $7.41 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9





